WO2009012908A3 - Arzneimittel zur transdermalen anwendung bei tieren - Google Patents
Arzneimittel zur transdermalen anwendung bei tieren Download PDFInfo
- Publication number
- WO2009012908A3 WO2009012908A3 PCT/EP2008/005747 EP2008005747W WO2009012908A3 WO 2009012908 A3 WO2009012908 A3 WO 2009012908A3 EP 2008005747 W EP2008005747 W EP 2008005747W WO 2009012908 A3 WO2009012908 A3 WO 2009012908A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- animals
- medicament
- transdermal use
- transdermal
- fur
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0814588-1A2A BRPI0814588A2 (pt) | 2007-07-26 | 2008-07-15 | Produtos farmacêuticos para uso transdérmico em animais |
US12/670,428 US20100197791A1 (en) | 2007-07-26 | 2008-07-15 | Pharmaceuticals for transdermal use on animals |
EP08773993A EP2182921A2 (de) | 2007-07-26 | 2008-07-15 | Arzneimittel zur transdermalen anwendung bei tieren |
CA2694386A CA2694386A1 (en) | 2007-07-26 | 2008-07-15 | Medicament for transdermal use on animals |
JP2010517293A JP2010534624A (ja) | 2007-07-26 | 2008-07-15 | 動物への経皮使用のための医薬 |
AU2008280501A AU2008280501A1 (en) | 2007-07-26 | 2008-07-15 | Medicament for transdermal use on animals |
ZA2010/00514A ZA201000514B (en) | 2007-07-26 | 2010-01-22 | Medicament for transdermal use on animals |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007034976A DE102007034976A1 (de) | 2007-07-26 | 2007-07-26 | Arzneimittel zur transdermalen Anwendung bei Tieren |
DE102007034976.0 | 2007-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009012908A2 WO2009012908A2 (de) | 2009-01-29 |
WO2009012908A3 true WO2009012908A3 (de) | 2009-06-11 |
Family
ID=40157239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/005747 WO2009012908A2 (de) | 2007-07-26 | 2008-07-15 | Arzneimittel zur transdermalen anwendung bei tieren |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100197791A1 (de) |
EP (1) | EP2182921A2 (de) |
JP (1) | JP2010534624A (de) |
AR (1) | AR067561A1 (de) |
AU (1) | AU2008280501A1 (de) |
BR (1) | BRPI0814588A2 (de) |
CA (1) | CA2694386A1 (de) |
CL (1) | CL2008002077A1 (de) |
DE (1) | DE102007034976A1 (de) |
PE (1) | PE20090797A1 (de) |
TW (1) | TW200922622A (de) |
UY (1) | UY31227A1 (de) |
WO (1) | WO2009012908A2 (de) |
ZA (1) | ZA201000514B (de) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0803254A1 (de) * | 1996-04-25 | 1997-10-29 | LUITPOLD PHARMA GmbH | Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel |
WO1999022716A1 (en) * | 1997-11-05 | 1999-05-14 | Nexmed Holdings, Inc. | Topical compositions for nsai drug delivery |
EP1044684A2 (de) * | 1999-04-13 | 2000-10-18 | Nitto Denko Corporation | Perkutan absorbierbare Zubereitung |
WO2004017998A2 (en) * | 2002-08-22 | 2004-03-04 | Novartis Consumer Health S.A. | Topical emulsion- gel composition comprising diclofenac sodium |
WO2004047795A2 (de) * | 2002-11-28 | 2004-06-10 | Bayer Healthcare Ag | Dermale applikation von flupirtin |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5855411A (ja) | 1981-09-28 | 1983-04-01 | Nitto Electric Ind Co Ltd | 基剤組成物および外用医薬組成物 |
EP0428352B1 (de) | 1989-11-14 | 1995-08-09 | Beta Pharmaceuticals Co. | Entzündungshemmende Arzneimittel zur äusserlichen Anwendung |
US5093133A (en) | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
TW206152B (de) | 1991-03-20 | 1993-05-21 | Kuko Seiyaku Kk | |
IL107448A0 (en) | 1992-10-30 | 1994-01-25 | Syntex Inc | Composition and device for transdermal delivery of ketorolac |
IT1291362B1 (it) | 1997-05-13 | 1999-01-07 | Vectorpharma Int | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
DE10025558A1 (de) | 2000-05-24 | 2001-11-29 | Merck Patent Gmbh | Topische Zusammensetzung, enthaltend mindestens ein Aryloxim, und Verfahren zu ihrer Herstellung |
PL367337A1 (en) | 2001-05-31 | 2005-02-21 | Pharmacia Corporation | Skin-permeable selective cyclooxygenase-2 inhibitor composition |
JP2003095983A (ja) | 2001-09-21 | 2003-04-03 | Lion Corp | 皮膚外用剤組成物 |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
-
2007
- 2007-07-26 DE DE102007034976A patent/DE102007034976A1/de not_active Withdrawn
-
2008
- 2008-07-15 WO PCT/EP2008/005747 patent/WO2009012908A2/de active Application Filing
- 2008-07-15 AU AU2008280501A patent/AU2008280501A1/en not_active Abandoned
- 2008-07-15 BR BRPI0814588-1A2A patent/BRPI0814588A2/pt not_active IP Right Cessation
- 2008-07-15 JP JP2010517293A patent/JP2010534624A/ja not_active Withdrawn
- 2008-07-15 CA CA2694386A patent/CA2694386A1/en not_active Abandoned
- 2008-07-15 EP EP08773993A patent/EP2182921A2/de not_active Withdrawn
- 2008-07-15 US US12/670,428 patent/US20100197791A1/en not_active Abandoned
- 2008-07-15 CL CL2008002077A patent/CL2008002077A1/es unknown
- 2008-07-16 PE PE2008001199A patent/PE20090797A1/es not_active Application Discontinuation
- 2008-07-16 UY UY31227A patent/UY31227A1/es not_active Application Discontinuation
- 2008-07-16 AR ARP080103051A patent/AR067561A1/es unknown
- 2008-07-25 TW TW097128223A patent/TW200922622A/zh unknown
-
2010
- 2010-01-22 ZA ZA2010/00514A patent/ZA201000514B/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0803254A1 (de) * | 1996-04-25 | 1997-10-29 | LUITPOLD PHARMA GmbH | Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel |
WO1999022716A1 (en) * | 1997-11-05 | 1999-05-14 | Nexmed Holdings, Inc. | Topical compositions for nsai drug delivery |
EP1044684A2 (de) * | 1999-04-13 | 2000-10-18 | Nitto Denko Corporation | Perkutan absorbierbare Zubereitung |
WO2004017998A2 (en) * | 2002-08-22 | 2004-03-04 | Novartis Consumer Health S.A. | Topical emulsion- gel composition comprising diclofenac sodium |
WO2004047795A2 (de) * | 2002-11-28 | 2004-06-10 | Bayer Healthcare Ag | Dermale applikation von flupirtin |
Also Published As
Publication number | Publication date |
---|---|
TW200922622A (en) | 2009-06-01 |
DE102007034976A1 (de) | 2009-01-29 |
WO2009012908A2 (de) | 2009-01-29 |
UY31227A1 (es) | 2009-03-02 |
EP2182921A2 (de) | 2010-05-12 |
CA2694386A1 (en) | 2009-01-29 |
US20100197791A1 (en) | 2010-08-05 |
ZA201000514B (en) | 2011-04-28 |
AR067561A1 (es) | 2009-10-14 |
JP2010534624A (ja) | 2010-11-11 |
AU2008280501A1 (en) | 2009-01-29 |
CL2008002077A1 (es) | 2009-01-30 |
PE20090797A1 (es) | 2009-07-23 |
BRPI0814588A2 (pt) | 2015-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006072589A3 (en) | Disubstituted ureas as kinase inhibitors | |
BRPI0924460A2 (pt) | composição farmacêutica para uso em oftalmologia médica e veterinária | |
BRPI1009860A2 (pt) | composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais | |
WO2010056922A3 (en) | Systems and methods for delivery of biologically active agents | |
WO2012149157A3 (en) | Heterocyclic compounds for the inhibition of pask | |
UY30373A1 (es) | Derivados de fenilalanina, procedimientos de preparacion y aplicaciones | |
DK2451445T3 (da) | Fremgangsmåde til at tørre bibw2992, dets salte og faste farmaceutiske formuleringer omfattende denne aktive ingrediens | |
BRPI0821110B8 (pt) | anticorpo de neutralização de anti-nr10/il31ra, composição farmacêutica compreendendo o referido anticorpo e uso do mesmo | |
WO2008087367A3 (fr) | Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations | |
WO2006081388A3 (en) | Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
WO2009061431A3 (en) | Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor | |
WO2013003827A3 (en) | Macrogol 15 hydroxystearate formulations | |
WO2007090661A3 (en) | Active substance combination comprising azolylcarbinol compounds | |
BRPI0909296A2 (pt) | uso de pelo menos um princípio ativo, e, composições cosmética, farmacêutica e/ou dermatológica | |
WO2012119046A3 (en) | Heterocyclic compounds for the inhibition of pask | |
WO2008105507A1 (ja) | 脊髄損傷治療薬剤 | |
IL284930A (en) | History of pyrrolopyrimidines and their use in the treatment of protein kinase-related diseases | |
BRPI0807867A2 (pt) | Derivado de indol ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um derivado de (indol-3-il) heterociclo, e, método de tratamento de dor | |
WO2011056871A3 (en) | Rhamnolipid mechanism | |
WO2007009686A3 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
WO2007098967A3 (en) | Imidazole compounds having pharmaceutical activity towards the sigma receptor | |
WO2005065713A3 (de) | Arzneimittel zur topischen applikation bei tieren | |
WO2007108883A3 (en) | High-deposition compositions and uses thereof | |
WO2006002846A3 (en) | New analogs of nitrobenzylthioinosine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08773993 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008773993 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2010/000078 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008280501 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2694386 Country of ref document: CA Ref document number: 582839 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12670428 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010517293 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2008280501 Country of ref document: AU Date of ref document: 20080715 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0814588 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100125 |